PI Industries' stock has fallen 18% since August, hitting 6-month lows on weak Q1 results, export headwinds, and regulatory issues in biologics, though brokerages stay divided
Near-term concerns likely to weigh on growth trajectory of PI Industries
PI Industries' stock has fallen 18% since August, hitting 6-month lows on weak Q1 results, export headwinds, and regulatory issues in biologics, though brokerages stay divided